Skip to main content

and
  1. No Access

    Protocol

    Methods for TALEN-Mediated Genomic Manipulations in Drosophila

    TALEN (transcription activator-like effector nuclease) is a powerful tool for gene disruption and other genomic modifications. In the past 3 years or so, it has attracted eyes from every corner of the biologic...

    Jiyong Liu, Yawen Guo, Changqing Li, Yixu Chen, Renjie Jiao in TALENs (2016)

  2. No Access

    Protocol

    Haplotype Inference

    Haplotypes, as they specify linkage patterns between individual nucleotide variants, confer critical information for understanding the genetics of human diseases. However, haplotype information is not directly...

    **n Li, **g Li in Statistical Human Genetics (2012)

  3. No Access

    Protocol

    Using ΦC31 Integrase to Mediate Insertion of DNA in Xenopus Embryos

    The two most common methods used to generate transgenic Xenopus embryos, restriction enzyme-mediated insertion, and I-SceI meganuclease take advantage of relatively common but spatially unpredictable double-stran...

    You E. Li, Bryan G. Allen, Daniel L. Weeks in Xenopus Protocols (2012)

  4. No Access

    Protocol

    Directed Evolution of Adeno-Associated Virus (AAV) as Vector for Muscle Gene Therapy

    Adeno-associated virus (AAV) is emerging as a vector of choice for muscle gene therapy because of its effective and stable transduction in striated muscles. AAV naturally evolve into multiple serotypes with di...

    Lin Yang, Juan Li, **ao **ao in Muscle Gene Therapy (2011)

  5. No Access

    Protocol

    Monitoring Murine Skeletal Muscle Function for Muscle Gene Therapy

    The primary function of skeletal muscle is to generate force. Muscle force production is compromised in various forms of acquired and/or inherited muscle diseases. An important goal of muscle gene therapy is t...

    Chady H. Hakim, Dejia Li, Dongsheng Duan in Muscle Gene Therapy (2011)

  6. No Access

    Protocol

    Exploiting Natural Diversity of AAV for the Design of Vectors with Novel Properties

    Twelve AAV serotypes have been described so far in human and nonhuman primate (NHP) populations while surprisingly high diversity of AAV sequences is detected in tissue biopsies. The analysis of these novel AA...

    Guang** Gao, Li Zhong, Olivier Danos in Adeno-Associated Virus (2011)

  7. No Access

    Protocol

    Gene Therapy in Skeletal Muscle Mediated by Adeno-Associated Virus Vectors

    Adeno-associated virus (AAV) is the most promising gene delivery vehicle for muscle-directed gene therapy. AAV’s natural tropism to muscle cells, long-term persistent transgene expression, multiple serotypes, ...

    Chun** Qiao, Taeyoung Koo, Juan Li, **ao **ao in Adeno-Associated Virus (2011)

  8. No Access

    Protocol

    Molecular Beacons for Protein—DNA Interaction Studies

    Real-time monitoring of DNA—protein interactions involving molecular beacon (MB) and molecular beacon aptamer (MBA) was discussed in this chapter. MBs are single-stranded oligonucleotide probes with a hairpin ...

    Jun Li, Zehui Charles Cao, Zhiwen Tang in Molecular Beacons: Signalling Nucleic Acid… (2008)

  9. No Access

    Protocol

    Lentiviral Vector Delivery of siRNA and shRNA Encoding Genes into Cultured and Primary Hematopoietic Cells

    Lentiviral vectors are able to transduce non-dividing cells and maintain sustained long-term expression of the transgenes. Many cell types including brain, liver, muscle, and hematopoietic stem cells have been...

    Mingjie Li, John J. Rossi in Gene Therapy Protocols (2008)

  10. No Access

    Protocol

    Design of Trans-Splicing Adeno-Associated Viral Vectors for Duchenne Muscular Dystrophy Gene Therapy

    The development of trans-splicing vectors opens the door for delivering a large therapeutic gene with adeno-associated viral vectors (AAV). One potential application is to deliver the 6 kb mini-dystrophin gene fo...

    Yi Lai, Dejia Li, Yong** Yue, Dongsheng Duan in Gene Therapy Protocols (2008)